Trianion synthon approach to spirocyclic heterocycles

Organic Letters

Volumn 15, Issue 9, 2013, Pages 2226-2229

  Perry, Matthew A ^a   Hill, Richard R ^a   Rychnovsky, Scott D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROCYCLIC COMPOUND; SPIRO COMPOUND;

ALKYLATION; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; STEREOISOMERISM; SYNTHESIS;

ALKYLATION; CYCLIZATION; HETEROCYCLIC COMPOUNDS; MOLECULAR STRUCTURE; SPIRO COMPOUNDS; STEREOISOMERISM;

EID: 84877153777     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol400788q     Document Type: Article

References (40)

1. Rajesh, S. M.; Perumal, S.; Menendez, J. C.; Yogeeswari, P.; Sriram, D. Med. Chem. Commun. 2011, 2, 626-630
2. Kotha, S.; Deb, A. C.; Lahiri, K.; Manivannan, E. Synthesis 2009, 2, 165-193
3. Takaoka, L. R.; Buckmelter, A. J.; La Cruz, T. E.; Rychnovsky, S. D. J. Am. Chem. Soc. 2005, 127, 528-529
4. La Cruz, T. E.; Rychnovsky, S. D. J. Org. Chem. 2006, 71, 1068-1073
5. La Cruz, T. E.; Rychnovsky, S. D. J. Org. Chem. 2007, 72, 2602-2611
6. Riberio, C. M. R.; Demelo, S. J.; Bonin, M.; Quirion, J. C.; Husson, H. P. Tetrahedron Lett. 1994, 35, 7227-7230
7. Biard, J. -F.; Guyot, S.; Roussakis, C.; Verbist, J.-F. Tetrahedron Lett. 1994, 35, 2691-2694
8. Issa, H.; Tanaka, J.; Rachmat, R.; Setiawan, A.; Trainto, A.; Higa, T. Mar. Drugs 2005, 3, 78-83
9. Hirasawa, Y.; Morita, H.; Kobayashi, J. Org. Lett. 2004, 6, 3389-3391
10. Daly, J. W.; Karle, I.; Myers, C. W.; Tokuyama, T.; Waters, J. A.; Witkop, B. Proc. Natl. Acad. Sci. U.S.A. 1971, 68, 1870
11. Burnell, R. H.; Mootoo, B. S. Can. J. Chem. 1961, 39, 1090
12. Blackman, A. J.; Li, C.; Hockless, D. C. R.; Skelton, B. H. Tetrahedron 1993, 49, 8645-8656
13. Blackman, A. J.; Li, C. Aust. J. Chem. 1994, 47, 1355-1361
14. Blackman, A. J.; Li, C. Aust. J. Chem. 1995, 48, 955-965
15. Sakamoto, K.; Tsujii, E.; Abe, F.; Nakanishi, T.; Yamashita, M.; Shigematsu, N.; Izumi, S.; Okuhara, M. J. Antibiot. 1996, 49, 37-44
16. Shirafuji, H.; Tsubotani, S.; Ishimaru, T.; Harada, S. PCT Int. Appl. WO 91 13,887, 1991
17. Chem Abstr. 1992, 116, 39780t.
18. (1) Sanofi-Aventis, Fr, WO2009EP04393, 2009, June 18.
19. (2) GlaxoSmithKline LLC, USA, WO2010US46782, 2010, August 26.
20. (3) Ghosh, A. K.; Krishnan, K.; Walters, D. E.; Cho, W.; Cho, H.; Koo, Y.; Trevino, J.; Holland, L.; Buthod, J. Bioorg. Med. Chem. Lett. 1998, 8, 979-982
21. (4) Glaxo Group Limited, UK, WO2008EP53595, 2008, March 27.
22. The Boots Company PLC, USA, US5610161, 1997, March 11.
23. Targacept, Inc., USA, WO2006034089, 2006, March 30.
24. Takeda Chemical Industries, Ltd., USA, US5591849, 1997, January 7.
25. Guillaume, D.; Brum-Bousquet, M.; Aitken, D. J.; Husson, H.-P. Bull. Soc. Chim. de Fran 1994, 131, 391-396
26. Perry, M. A.; Morin, M. D.; Slafer, B. W.; Wolckenhauer, S. A.; Rychnovsky, S. D. J. Am. Chem. Soc. 2010, 132, 9591-9593
27. Perry, M. A.; Morin, M. D.; Slafer, B. W.; Rychnovsky, S. D. J. Org. Chem. 2012, 77, 3390-3400
28. Gharpure, S. J.; Reddy, S. R. B. Org. Lett. 2009, 11, 2519-2522
29. Fleming, F. F.; Zhang, Z. Tetrahedron 2005, 61, 747-789
30. Fleming, F. F.; Shook, B. C. Tetrahedron 2002, 58, 1-23 and references cited therein
31. Soorukram, D.; Knochel, P. Org. Lett. 2004, 6, 2409-2411
32. Guijarro, D.; Yus, M. Tetrahedron 1994, 50, 3447-3452
33. Ramon, D.; Yus, M. Tetrahedron 1992, 48, 3585-3588
34. Gomez, C.; Lillo, V. J.; Yus, M. Tetrahedron 2007, 93, 4655-4662
35. Bahde, R. J.; Rychnovsky, S. D. Org. Lett. 2008, 10, 4017-4020
36. Bonjoch, J.; Diaba, F.; Puigbó, G.; Peidró, E.; Solé, D. Tetrahedron Lett. 2003, 44, 8387-8390
37. Nagumo, S.; Matoba, A.; Ishii, Y.; Yamaguchi, S.; Akutsu, N.; Nishijima, H.; Nishida, A.; Kawahara, N. Tetrahedron 2002, 58, 9871-9877
38. Sanofi-Aventis, Fr, WO2009156092, 2009, December 30.
39. Sunovion Pharmaceuticals, Inc., USA, WO2011075699, 2011, June 23.
40. Rotta Research Laboratorium S.p.A., Italy, US6075033, 2000, June 13.